Skip to main content
Clinical Trials/DRKS00007644
DRKS00007644
Completed
未知

Influence of effective noninvasive positive pressure ventilation on biomarkers in stable hypercapnic COPD patients

Firma Resmed0 sites20 target enrollmentJanuary 23, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
J44.9
Sponsor
Firma Resmed
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2015
End Date
October 19, 2012
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Firma Resmed

Eligibility Criteria

Inclusion Criteria

  • COPD patients in stadium GOLD iV with hypercapnia (PaCO2 \> 50 mmHg)
  • Stable state of disease (pH \>7,33\)

Exclusion Criteria

  • Severe Obesity (BMI \> 35 kg/m2\)
  • Restrictive lung disease (total lung capacity \<80%)
  • Acute infections including acute pulmonary exacerbation
  • Chronic inflammatory diseases other than COPD or atherosclerosis that could be potential confounders (e.g. rheumatic disease, collagenoses, etc.)
  • Malignant disease
  • Anti\-inflammatory or immunosuppressive drugs other than statins, aspirin or clopidogrel

Outcomes

Primary Outcomes

Not specified

Similar Trials